Please ensure Javascript is enabled for purposes of website accessibility Cir.No.174 of 2024 - Regarding Field Safety Corrective Action of ACURATE neoTM and ACURATE PrimeTM Aortic Valve Systems (Transcatheter Aortic Valve Implantation (TAVI)) from (mr: Boston Scientific). Cir.No.174 of 2024 - Regarding Field Safety Corrective Action of ACURATE neoTM and ACURATE PrimeTM Aortic Valve Systems (Transcatheter Aortic Valve Implantation (TAVI)) from (mr: Boston Scientific).
Alert :

Welcome to the beta version of the eHealth portal; our goal is to improve your experience by providing better eServices

Cir.No.174 of 2024 - Regarding Field Safety Corrective Action of ACURATE neoTM and ACURATE PrimeTM Aortic Valve Systems (Transcatheter Aortic Valve Implantation (TAVI)) from (mr: Boston Scientific).

Content Details
Medical devices and equipment department News and Safety Alerts
Cir.No.174 of 2024 - Regarding Field Safety Corrective Action of ACURATE neoTM and ACURATE PrimeTM Aortic Valve Systems (Transcatheter Aortic Valve Implantation (TAVI)) from (mr: Boston Scientific).
23/12/2024

Regarding Field Safety Corrective Action of ACURATE neoTM and ACURATE PrimeTM Aortic Valve Systems (Transcatheter Aortic Valve Implantation (TAVI)) from (mr: Boston Scientific).

3
Cir.No.174 of 2024 - Regarding Field Safety Corrective Action of ACURATE neoTM and ACURATE PrimeTM Aortic Valve Systems (Transcatheter Aortic Valve Implantation (TAVI)) from (mr: Boston Scientific).
Was this page helpful?
0 visitors liked this page of total 0 visitors
Be the first to evaluate this page

Add Reason (choose at least one)

الرجاء اختيار سببان كحد أعلى

هذا الحقل مطلوب

الرجاء كتابة نص صحيح

الملاحظات يجب ان تكون اقل من ٢٥٠ حرف

Share this page
Follow Us On